SelectScience
Join Free
Accelerating Science
ResourceLife Sciences

Smarter cleanup for lentiviral manufacturing

ArcticZymes
29 Jul 2025

Discover how ArcticZymes Technologies' M-SAN HQ nuclease enhances lentiviral vector manufacturing by efficiently removing host cell DNA, including chromatin, under physiological salt conditions. This simple yet powerful solution helps improve vector yield, streamline downstream processing, and reduce regulatory risks.

Related products

Request Quote for All Products

Bioprocessing Salt Active Nucleases - Physiological Conditions

ArcticZymes

Nonspecific endonuclease is highly active at physiological conditions (125–200 mM) for DNA removal during protein production, vaccine manufacturing, and viral vector preparation. M-SAN High Quality can be used directly in cell media, which improves efficiency and yield. Designed to replace Benzonase without workflow changes. M-SAN HQ excels in ensuring higher purity and efficiency. High purity (≥ 99%). Compatible with ELISA kit.

(0)

Links

ArcticZymesCompany website

Tags

BiomanufacturingGene TherapyGene therapy is a technique that modifies or replaces genes within an individual's cells to treat or prevent diseases. This approach holds potential for curing genetic disorders, cancers, and certain viral infections. Advances in gene editing technologies like CRISPR are driving the growth of gene therapy. Explore gene therapy tools and technologies in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.BioprocessingBioprocessing is the use of biological systems for the conversion of raw materials to desired products. This includes the research, development and manufacturing stages of production and can refer to food processing, small-molecule pharmaceutical manufacture, production of recombinant protein therapeutics, or the generation of renewable energy.Lentivirus

Related resources

Smarter cleanup for lentiviral manufacturing